Certain cancers require the amino acid arginine. Arginine deiminase (ADI) is an enzyme from
microbes that degrade arginine. ADI has been formulated with polyethylene glycol and has been
used to treat patients that have cancers that require arginine. In this study, the
investigators will evaluate the response rate, as determined by the revised International
Working Group recommendations.